These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20225046)

  • 1. Lentiviral vector engineering for anti-HIV RNAi gene therapy.
    ter Brake O; Westerink JT; Berkhout B
    Methods Mol Biol; 2010; 614():201-13. PubMed ID: 20225046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
    Liu YP; Westerink JT; ter Brake O; Berkhout B
    Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
    Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
    Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
    Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
    Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells].
    Liu YH; Li JM; Zhou J; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
    von Eije KJ; ter Brake O; Berkhout B
    J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx].
    Kim JW; Lee SH; Park YS; Jeong SH; Kim N; Lee DH
    Korean J Hepatol; 2009 Mar; 15(1):15-24. PubMed ID: 19346782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
    Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
    Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of multicopy shRNA lentiviral vectors for antiviral therapy.
    Henry SD; Pan Q; van der Laan LJ
    Methods Mol Biol; 2011; 721():313-32. PubMed ID: 21431694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
    Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the quantitative expression of a costimulatory molecule on dendritic cells using lentiviral vector-mediated RNA interference.
    Zhang L; Procuik M; Fang T; Kung SK
    J Immunol Methods; 2009 May; 344(2):87-97. PubMed ID: 19303417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RNA silencing technology applied by lentiviral vectors in oncology.
    Sumimoto H; Kawakami Y
    Methods Mol Biol; 2010; 614():187-99. PubMed ID: 20225045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
    Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
    Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and cloning of lentiviral vectors expressing small interfering RNAs.
    Tiscornia G; Singer O; Verma IM
    Nat Protoc; 2006; 1(1):234-40. PubMed ID: 17406238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.
    Rubinson DA; Dillon CP; Kwiatkowski AV; Sievers C; Yang L; Kopinja J; Rooney DL; Zhang M; Ihrig MM; McManus MT; Gertler FB; Scott ML; Van Parijs L
    Nat Genet; 2003 Mar; 33(3):401-6. PubMed ID: 12590264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.